Response to Neoadjuvant Chemotherapy in Breast Cancer Could be Predictable by Measuring a Novel Serum Apoptosis Product, Caspase-Cleaved Cytokeratin 18: A Prospective Pilot Study

@article{citeulike:1072409, author = {Demiray and Mutlu and Ulukaya and Engin, Engin and Arslan and Murat and Gokgoz and Sehsuvar and Saraydaroglu and Ozlem and Ercan and Ilker and Evrensel and Turkkan and Manavoglu and Osman}, citeulike-article-id = {1072409}, doi = {http://dx.doi.org/10.1080/07357900600981307}, issn = {0735-7907}, journal = {Cancer Investigation}, month = {November}, number = {7}, pages = {669--676}, posted-at = {}, publisher = {Taylor and Francis Ltd}, title = {Response to Neoadjuvant Chemotherapy in Breast Cancer Could be Predictable by Measuring a Novel Serum Apoptosis Product, Caspase-Cleaved Cytokeratin 18: A Prospective Pilot Study}, url = {http://dx.doi.org/10.1080/07357900600981307}, volume = {24}, year = {2006} }

TY - JOUR ID - citeulike:1072409 L3 - citeulike-article-id:1072409 TI - Response to Neoadjuvant Chemotherapy in Breast Cancer Could be Predictable by Measuring a Novel Serum Apoptosis Product, Caspase-Cleaved Cytokeratin 18: A Prospective Pilot Study JF - Cancer Investigation VL - 24 IS - 7 SP - 669 EP - 676 PB - Taylor and Francis Ltd SN - 0735-7907 AU - Demiray AU - Mutlu AU - Ulukaya AU - Engin, Engin AU - Arslan AU - Murat AU - Gokgoz AU - Sehsuvar AU - Saraydaroglu AU - Ozlem AU - Ercan AU - Ilker AU - Evrensel AU - Turkkan AU - Manavoglu AU - Osman PY - 2006/11// UR - http://dx.doi.org/10.1080/07357900600981307 ER -